Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial - Media Centre | EASD
Effects of exenatide on urinary albumin in overweight/obese patients with T2DM: a randomized clinical trial | Scientific Reports
ADA: Efficacy and Safety of Lixisenatide Once-Daily vs. Exenatide Twice-Daily in Type 2 DM Inadequately Controlled on Metformin (GetGoal-X)
Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin- exenatide study | BMC
Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes - Wysham - 2018 - Diabetes, Obesity and Metabolism - Wiley Online Library
Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes mellitus: A pooled analysis - ScienceDirect
Estimated average daily usage and cost of exenatide BiD and liraglutide... | Download Table
The metabolic effects of adding exenatide to basal insulin therapy when targeting remission in early type 2 diabetes in a randomized clinical trial | Nature Communications
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin - Endocrine Practice
Simulated progression of HbA1c in exenatide BID þ OAD (treatment arm)... | Download Scientific Diagram
Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes | Diabetes Technology & Therapeutics
DATA SHEET
Mean direct medical cost (€) per patient receiving exenatide bid or... | Download Table
Exenatide Effects on Glycemic Control in Type 2 Diabetes
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
Efficacy and Safety of Exenatide versus Insulin in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
Bydureon® (exenatide once weekly) clinical data slide deck - ppt download
Product Information for Exenatide
Overview of clinical trials comparing liraglutide qd with exenatide... | Download Table
Exenatide - wikidoc
NDA 21773 WRITTEN REQUEST – AMENDMENT # 8 AstraZeneca AB C/O AstraZeneca Pharmaceuticals LP Attention: Jeffy G. John, MBA Dire
Overview of clinical trials comparing liraglutide qd with exenatide... | Download Table
Abstract 13242: Risk of Cardiovascular Events in Patients with Type 2 Diabetes Treated With Exenatide BID or Other Glucose-Lowering Therapies: A Retrospective Analysis of the LifeLinkTM Database | Circulation
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes | Cardiovascular Diabetology | Full Text
Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes | Cardiovascular Diabetology | Full Text
Table 1 from Exenatide ( Byetta ) , an Incretin Mimetic : The First in a New Therapeutic Class in the Treatment of Diabetes | Semantic Scholar
